Dr. Jason Andrews is a tenured Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine in the Department of Medicine at Stanford University. His research focuses on development and testing of novel tools for characterizing the burden and transmission of tuberculosis and tropical infectious diseases. His lab employs a diverse of set of methodologies from genomic epidemiology and molecular biology to mathematical modeling and clinical and field epidemiology studies in low- and middle-income countries. His mathematical modeling work on cost-effectiveness of mass drug administration for schistosomiasis and vaccine introduction strategies for typhoid fever were cited in WHO guidelines and position statements. His lab has led the development of several diagnostic assays for tuberculosis and tropical diseases, including: 1) a rapid pharmacogenomic assay to guide personalized tuberculosis treatment dosing; 2) a novel point-of-care serodiagnostic for typhoid fever that exceeds the accuracy of all commercially available diagnostics; and 3) a low-cost bacteriophage-based assay for mapping environmental abundance of typhoidal Salmonella. Dr. Andrews’ lab led the largest Salmonella Typhi sequencing and phylogeographic study to date, which revealed extensive international and intercontinental spread of drug-resistant typhoid. His group led the development of a novel seroepidemiology approach to estimating incidence of typhoid fever from dried blood spots, cited in forthcoming WHO guidance on burden estimation. He has served as Principal Investigator for 9 NIH awards, including a Director’s New Innovator Award, four R01 awards and a K24 award for mentorship. Dr. Andrews has mentored more than three dozen students and postdoctoral fellows, many of whom have gone on to establish successful independent research groups. He has published more than 270 peer-reviewed papers and served on working groups for the CDC and WHO.